Dopaminergic differentiation of human embryonic stem cells

Stem Cells

Volumn 22, Issue 6, 2004, Pages 925-940

  Zeng, Xianmin ^a   Cai, Jingli ^b   Chen, Jia ^a   Luo, Yongquan ^b   You, Zhi Bing ^a   Fotter, Erin ^a   Wang, Yun ^a   Harvey, Brandon ^a   Miura, Takumi ^b   Backman, Cristina ^a   Chen, Guann Juh ^a   Rao, Mahendra S ^b   Freed, William J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Dopaminergic PA6 stromal cells; Embryonic stem cells; Hepatocyte growth factor; Neuronal differentiation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACTIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BONE MORPHOGENETIC PROTEIN 4; BROXURIDINE; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; NORADRENALIN; NUCLEAR RECEPTOR RELATED FACTOR 1; OXIDOPAMINE; POTASSIUM ION; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LMX1B; TRANSCRIPTION FACTOR PTX3; TRANSCRIPTION FACTOR SOX1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EMBRYO; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; NORADRENERGIC NERVE; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALIA;

EID: 8644259350     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.22-6-925     Document Type: Article

References (52)

1. Collier TJ, Steece-Collier K, McGuire S et al. Cellular models to study dopaminergic injury responses. Ann N Y Acad Sci 2003;991:140-151.
2. Lindvall O, Hagell P. Cell therapy and transplantation in Parkinson's disease. Clin Chem Lab Med 2001;39:356-361.
3. Perrier AL, Studer L. Making and repairing the mammalian brain: in vitro production of dopaminergic neurons. Semin Cell Dev Biol 2003;14:181-189.
4. Jentsch JD, Roth RH, Taylor JR. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res 2000;126:433-453.
5. Pierce RC, Bari AA. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev Neurosci 2001;12:95-110.
6. Volkow ND, Fowler JS, Wang GJ et al. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol 2002;12:557-566.
7. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
8. Bjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002;99:2344-2349.
9. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418:50-56.
10. Carpenter MK, Inokuma MS, Denham J et al. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 2001;172:383-397.
11. Reubinoff BE, Itsykson P, Turetsky T et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001;19:1134-1140.
12. Zhang SC, Wernig M, Duncan ID et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1129-1133.
13. Kehat I, Gepstein A, Spira A et al. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 2002;91:659-661.
14. Xu C, Police S, Rao N et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-508.
15. Rambhatla L, Chiu CP, Kundu Pet al. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003;12:1-11.
16. Assady S, Maor G, Amit M et al. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691-1697.
17. Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2001;98:10716-10721.
18. Kawasaki H, Mizuseki K, Nishikawa S et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000;28:31-40.
19. Kawasaki H, Suemori H, Mizuseki K et al. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci U S A 2002;99:1580-1585.
20. Zeng X, Miura T, Luo Y et al. Properties of pluripotent human embryonic stem cells BG01 and BG02. STEM CELLS 2004;22:292-312.
21. Zeng X, Chen J, Sanchez JF et al. Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. STEM CELLS 2003;21:647-653.
22. Luo Y, Cai J, Ginis I et al. Designing, testing and validating a stem cell microarray for characterization of neural stem cells and progenitor cells. STEM CELLS 2003;21:575-587.
23. Wang Y, Lin JC, Chiou AL et al. Human ventromesencephalic grafts restore dopamine release and clearance in hemiparkinsonian rats. Exp Neurol 1995;136:98-106.
24. Park S, Lee KS, Lee YJ et al. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci Lett 2004;359:99-103.
25. Park S, Kim EY, Ghil GS et al. Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Neurosci Lett 2003;353:91-94.
26. Lindvall O. Stem cells for cell therapy in Parkinson's disease. Pharmacol Res 2003;47:279-287.
27. Marchionini DM, Collier TJ, Camargo M et al. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J Comp Neurol 2003;464:172-179.
28. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-973.
29. Lindvall O, Bjorklund A. Anatomy of the dopaminergic neuron systems in the rat brain. Adv Biochem Psychopharmacol 1978;19:1-23.
30. Simon HH, Bhatt L, Gherbassi D et al. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann N Y Acad Sci 2003;991:36-47.
31. Liu J, Merlie JP, Todd RD et al. Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis. Brain Res Mol Brain Res 1997;50:33-42.
32. Sakurada K, Ohshima-Sakurada M, Palmer TD et al. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 1999;126:4017-4026.
33. Ye W, Shimamura K, Rubenstein JL et al. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998;93:755-766.
34. Pevny LH, Sockanathan S, Placzek M et al. A role for SOX1 in neural determination. Development 1998;125:1967-1978.
35. Zetterstrom RH, Solomin L, Jansson L et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997;276:248-250.
36. Smidt MP, Asbreuk CH, Cox JJ et al. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci 2000;3:337-341.
37. Wang MZ, Jin P, Bumcrot DA, Mango V et al. Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat Med 1995;1:1184-1188.
38. Ericson J, Muhr J, Placzek M et al. Sonic hedgehog induces the differentiation of ventral forebrain neurons: a common signal for ventral patterning within the neural tube. Cell 1995;81:747-756.
39. Murone M, Rosenthal A, de Sauvage FJ. Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr Biol 1999;9:76-84.
40. Marigo V, Davey RA, Zuo Y et al. Biochemical evidence that patched is the Hedgehog receptor. Nature 1996;384:176-179.
41. Stone DM, Hynes M, Armanini M et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 1996;384:129-134.
42. MacArthur CA, Lawshe A, Xu J et al. FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 1995;121:3603-3613.
43. Hyman C, Hofer M, Barde YA et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991;350:230-232.
44. Knusel B, Winslow JW, Rosenthal A et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci U S A 1991;88:961-965.
45. Lin LF, Doherty DH, Lile JD et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130-1132.
46. Erickson JT, Brosenitsch TA, Katz DM. Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo. J Neurosci 2001;21:581-589.
47. Soppet D, Escandon E, Maragos J et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 1991;65:895-903.
48. Klein R, Nanduri V, Jing SA et al. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991;66:395-403.
49. Nosrat CA, Tomac A, Hoffer BJ et al. Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp Brain Res 1997;115:410-422.
50. Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 2001;12:361-373.
51. Ginis I, Luo Y, Miura T et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004;269:360-380.
52. Hamanoue M, Takemoto N, Matsumoto K et al. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 1996;43:554-564.